Literature DB >> 11003979

NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes.

Y P Li1, M B Reid.   

Abstract

Nuclear factor-kappaB (NF-kappaB) regulates the transcription of a variety of genes involved in immune responses, cell growth, and cell death. However, the role of NF-kappaB in muscle biology is poorly understood. We recently reported that tumor necrosis factor-alpha (TNF-alpha) rapidly activates NF-kappaB in differentiated skeletal muscle myotubes and that TNF-alpha acts directly on the muscle cell to induce protein degradation. In the present study, we ask whether NF-kappaB mediates the protein loss induced by TNF-alpha. We addressed this problem by creating stable, transdominant negative muscle cell lines. C2C12 myoblasts were transfected with viral plasmid constructs that induce overexpression of mutant I-kappaBalpha proteins that are insensitive to degradation via the ubiquitin-proteasome pathway. These mutant proteins selectively inhibit NF-kappaB activation. We found that differentiated myotubes transfected with the empty viral vector (controls) underwent a drop in total protein content and in fast-type myosin heavy-chain content during 72 h of exposure to TNF-alpha. In contrast, total protein and fast-type myosin heavy-chain levels were unaltered by TNF-alpha in the transdominant negative cell lines. TNF-alpha did not induce apoptosis in any cell line, as assessed by DNA ladder and annexin V assays. These data indicate that NF-kappaB is an essential mediator of TNF-alpha-induced catabolism in differentiated muscle cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003979     DOI: 10.1152/ajpregu.2000.279.4.R1165

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  135 in total

Review 1.  Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.

Authors:  Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini
Journal:  Ageing Res Rev       Date:  2010-05-14       Impact factor: 10.895

2.  Liver kinase B1 inhibits the expression of inflammation-related genes postcontraction in skeletal muscle.

Authors:  Ting Chen; Timothy M Moore; Mark T W Ebbert; Natalie L McVey; Steven R Madsen; David M Hallowell; Alexander M Harris; Robin E Char; Ryan P Mackay; Chad R Hancock; Jason M Hansen; John S Kauwe; David M Thomson
Journal:  J Appl Physiol (1985)       Date:  2016-01-21

3.  Modeling the Effect of TNF-α upon Drug-Induced Toxicity in Human, Tissue-Engineered Myobundles.

Authors:  Brittany N J Davis; Jeffrey W Santoso; Michaela J Walker; Catherine E Oliver; Michael M Cunningham; Christian A Boehm; Danielle Dawes; Samantha L Lasater; Kim Huffman; William E Kraus; George A Truskey
Journal:  Ann Biomed Eng       Date:  2019-04-08       Impact factor: 3.934

4.  Rel A/p65 is required for cytokine-induced myotube atrophy.

Authors:  Takuo Yamaki; Chia-Ling Wu; Michael Gustin; Jamie Lim; Robert W Jackman; Susan C Kandarian
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-16       Impact factor: 4.249

5.  NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy.

Authors:  Ramon C J Langen; Astrid Haegens; Juanita H J Vernooy; Emiel F M Wouters; Menno P J de Winther; Harald Carlsen; Chad Steele; Steven E Shoelson; Annemie M W J Schols
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-26       Impact factor: 6.914

6.  PGC-1α overexpression by in vivo transfection attenuates mitochondrial deterioration of skeletal muscle caused by immobilization.

Authors:  Chounghun Kang; Craig A Goodman; Troy A Hornberger; Li Li Ji
Journal:  FASEB J       Date:  2015-07-15       Impact factor: 5.191

7.  Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.

Authors:  J N Gordon; T M Trebble; R D Ellis; H D Duncan; T Johns; P M Goggin
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 8.  Skeletal muscle changes after hemiparetic stroke and potential beneficial effects of exercise intervention strategies.

Authors:  Charlene E Hafer-Macko; Alice S Ryan; Frederick M Ivey; Richard F Macko
Journal:  J Rehabil Res Dev       Date:  2008

9.  Exaggerated expression of skeletal muscle-derived interleukin-6, but not TNFalpha, in mice lacking interleukin-10.

Authors:  Kimberly A Huey; Robert H McCusker; Keith W Kelley
Journal:  J Neuroimmunol       Date:  2008-06-18       Impact factor: 3.478

Review 10.  Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.

Authors:  Norman Mangner; Yae Matsuo; Gerhard Schuler; Volker Adams
Journal:  Endocrine       Date:  2012-08-19       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.